| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.028 | 0.7 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |